Skip to main content

Table 2 Demographic and clinicopathological characteristics of the study patients by BMI

From: Effects of duodenal transection timing on clinical short-term outcomes of patients with laparoscopic spleen-preserving splenic hilar lymphadenectomy for advanced proximal gastric cancer

Characteristics

BMI ≥ 24 (kg/m2)

P value

BMI < 24 (kg/m2)

P value

CG (n = 18)

EG (n = 23)

CG (n = 39)

EG (n = 47)

Age (years)

59.5 ± 9.7

57.8 ± 9.6

0.573

60.10 ± 10.9

59.13 ± 10.3

0.673

Sex

 Male (n)

11

15

0.786

25

30

0.782

 Female (n)

7

8

 

14

17

 

 BMI (kg/m2)

25.81 ± 1.1

25.65 ± 1.0

0.637

20.1 ± 1.5

20.4 ± 1.7

0.496

 Tumor size (cm)

3.12 ± 0.8

3.29 ± 0.7

0.449

3.07 ± 0.6

3.11 ± 0.7

0.746

ASA score (n)

      

 I

8

10

1.000

14

16

1.000

 II

6

7

 

16

20

 

 III

4

6

 

9

11

 

T-stage (n)

  

0.995

  

0.969

 T2

4

5

 

9

10

 

 T3

8

10

 

20

24

 

 T4a

6

8

 

10

13

 

N-stage (n)

  

0.630

  

0.713

 N0

3

4

 

7

9

 

 N1

5

10

 

12

10

 

 N2

4

5

 

9

15

 

 N3

6

4

 

11

13

 

TNM stage (n)

  

0.593

  

0.398

 I

5

6

 

8

7

 

 II

6

11

 

21

32

 

 III

7

6

 

10

8

 

Histologic grade (n)

      

 Differentiated

7

10

0.767

17

21

0.919

 Undifferentiated

11

13

 

22

26

 
  1. Note: Differentiated: papillary or well/moderately differentiated tubular adenocarcinoma. Undifferentiated: poorly differentiated or mucinous adenocarcinoma or signet-ring cell carcinoma. P values indicate comparisons between CG and EG
  2. Abbreviations: CG conventional group, EG experimental group, ASA American Society of Anesthesiologists, BMI body mass index, TNM tumor node metastasis staging, n number of patients